Effect of chronic administration of cisapride on gastric emptying of a solid meal and on dyspeptic symptoms in patients with idiopathic gastroparesis
- PMID: 3552906
- PMCID: PMC1432703
- DOI: 10.1136/gut.28.3.300
Effect of chronic administration of cisapride on gastric emptying of a solid meal and on dyspeptic symptoms in patients with idiopathic gastroparesis
Abstract
In a double blind crossover comparison with placebo, the effects of cisapride (10 mg tid for two weeks), a non-antidopaminergic gastrointestinal prokinetic drug, on gastric emptying times and on symptoms were evaluated in 12 patients with chronic idiopathic dyspepsia and gastroparesis. Gastric emptying was studied by a radioisotopic gamma camera technique. The test meal was labelled in the solid component (99mTc-sulphur colloid infiltrated chicken liver). Nine symptoms (nausea, belching, regurgitations, vomiting, postprandial drowsiness, early satiety, epigastric pain or burning, heartburn) were graded weekly on a questionnaire. Cisapride was significantly more effective than placebo in shortening the t1/2 of gastric emptying (p2 = 0.04), but no significant difference was observed between the two treatments with regard to the improvement of total symptom score (p2 = 0.09). No side effects were reported during the study.
Similar articles
-
Comparative effects of levosulpiride and cisapride on gastric emptying and symptoms in patients with functional dyspepsia and gastroparesis.Aliment Pharmacol Ther. 2000 May;14(5):561-9. doi: 10.1046/j.1365-2036.2000.00742.x. Aliment Pharmacol Ther. 2000. PMID: 10792119 Clinical Trial.
-
Cisapride and gastric emptying of a solid meal in dyspeptic diabetics without autonomic neuropathy and in healthy volunteers.Eur J Clin Pharmacol. 1989;37(4):411-3. doi: 10.1007/BF00558512. Eur J Clin Pharmacol. 1989. PMID: 2598976 Clinical Trial.
-
Measurement of gastric emptying in dyspeptic patients: effect of a new gastrokinetic agent (cisapride).Gut. 1985 Apr;26(4):352-8. doi: 10.1136/gut.26.4.352. Gut. 1985. PMID: 3884468 Free PMC article. Clinical Trial.
-
Diabetic gastroparesis. A critical reappraisal of new treatment strategies.Drugs. 1992 Oct;44(4):537-53. doi: 10.2165/00003495-199244040-00002. Drugs. 1992. PMID: 1281070 Review.
-
Efficacy of cisapride in the treatment of epigastric pain and concomitant symptoms in non-ulcer dyspepsia.Scand J Gastroenterol Suppl. 1989;165:54-8. doi: 10.3109/00365528909091231. Scand J Gastroenterol Suppl. 1989. PMID: 2690325 Review.
Cited by
-
Clinical Features, Risk Factors, and Endoscopic Treatment of Bezoars: A Retrospective Analysis from a Single Center in Northern China.Med Sci Monit. 2020 Oct 7;26:e926539. doi: 10.12659/MSM.926539. Med Sci Monit. 2020. PMID: 33027245 Free PMC article.
-
Intestinal motility in irritable bowel syndrome: is IBS a motility disorder? Part 2. Motility of the small bowel, esophagus, stomach, and gall-bladder.Dig Dis Sci. 1993 Oct;38(10):1773-82. doi: 10.1007/BF01296098. Dig Dis Sci. 1993. PMID: 8404396 Review. No abstract available.
-
Open label study of long-term effectiveness of cisapride in patients with idiopathic gastroparesis.Dig Dis Sci. 1994 Jul;39(7):1395-8. doi: 10.1007/BF02088039. Dig Dis Sci. 1994. PMID: 8026248 Clinical Trial.
-
Gastroparesis: current concepts and management.Gut Liver. 2009 Sep;3(3):166-73. doi: 10.5009/gnl.2009.3.3.166. Epub 2009 Sep 30. Gut Liver. 2009. PMID: 20431741 Free PMC article.
-
Bayesian inverse methods for spatiotemporal characterization of gastric electrical activity from cutaneous multi-electrode recordings.PLoS One. 2019 Oct 14;14(10):e0220315. doi: 10.1371/journal.pone.0220315. eCollection 2019. PLoS One. 2019. PMID: 31609972 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical